Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 241 articles:
HTML format
Text format



Single Articles


    September 2019
  1. YU J, Ouyang W, Li C, Shen J, et al
    Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition.
    BMC Cancer. 2019;19:927.
    PubMed     Text format     Abstract available


  2. SUN XS, Liang YJ, Liu SL, Chen QY, et al
    Maximal standard uptake values of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
    BMC Cancer. 2019;19:908.
    PubMed     Text format     Abstract available


  3. XU F, Zhang S, Liu Z, Gu J, et al
    TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:875.
    PubMed     Text format     Abstract available


    August 2019
  4. WU L, Zheng K, Yan C, Pan X, et al
    Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:843.
    PubMed     Text format     Abstract available


  5. SHENG X, Li Y, Li Y, Liu W, et al
    PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.
    BMC Cancer. 2019;19:840.
    PubMed     Text format     Abstract available


  6. QADIR F, Lalli A, Dar HH, Hwang S, et al
    Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma.
    BMC Cancer. 2019;19:830.
    PubMed     Text format     Abstract available


  7. VERDONCK-DE LEEUW IM, Jansen F, Brakenhoff RH, Langendijk JA, et al
    Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank.
    BMC Cancer. 2019;19:765.
    PubMed     Text format     Abstract available


    July 2019
  8. FU X, Li T, Dai Y, Li J, et al
    Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:721.
    PubMed     Text format     Abstract available


  9. REZAEI M, Khamaneh AM, Zarghami N, Vosoughi A, et al
    Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
    BMC Cancer. 2019;19:690.
    PubMed     Text format     Abstract available


  10. TANG X, Sun Y, Wan G, Sun J, et al
    Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/beta-catenin pathway.
    BMC Cancer. 2019;19:654.
    PubMed     Text format     Abstract available


  11. CHEN Y, Yang Z, Wang Y, Wang J, et al
    Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer.
    BMC Cancer. 2019;19:651.
    PubMed     Text format     Abstract available


    June 2019
  12. RUUSKANEN M, Leivo I, Minn H, Vahlberg T, et al
    Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:624.
    PubMed     Text format     Abstract available


  13. LIU C, Xiao C, Chen J, Li X, et al
    Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    BMC Cancer. 2019;19:622.
    PubMed     Text format     Abstract available


  14. YANG Y, Zhang X, Li B, Li Z, et al
    Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally
    BMC Cancer. 2019;19:608.
    PubMed     Text format     Abstract available


  15. ZENG B, Zhang X, Zhao J, Wei Z, et al
    The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:609.
    PubMed     Text format     Abstract available


  16. QIAN Z, Wei B, Zhou Y, Wang Q, et al
    PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:585.
    PubMed     Text format     Abstract available


  17. LIU F, Luo T, Jin T, Zhang J, et al
    Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
    BMC Cancer. 2019;19:554.
    PubMed     Text format     Abstract available


  18. YANG WH, Yang YH, Chen PC, Wang TC, et al
    Intracranial aneurysms formation after radiotherapy for head and neck cancer: a 10-year nationwide follow-up study.
    BMC Cancer. 2019;19:537.
    PubMed     Text format     Abstract available


    May 2019
  19. YANG Y, Huang X, Zhou L, Deng T, et al
    Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    BMC Cancer. 2019;19:526.
    PubMed     Text format     Abstract available


  20. JIANG F, Yu W, Zeng F, Cheng G, et al
    PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:503.
    PubMed     Text format     Abstract available


  21. WANG Q, Wu Z, Zhan T, Fang S, et al
    Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
    BMC Cancer. 2019;19:500.
    PubMed     Text format     Abstract available


  22. LI C, Wang X, Wang X, Han C, et al
    Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study proto
    BMC Cancer. 2019;19:492.
    PubMed     Text format     Abstract available


  23. YANG Z, Liao J, Carter-Cooper BA, Lapidus RG, et al
    Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
    BMC Cancer. 2019;19:485.
    PubMed     Text format     Abstract available


  24. WANG K, Dong J, He S, Wang X, et al
    Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    BMC Cancer. 2019;19:482.
    PubMed     Text format     Abstract available


  25. HUANG TX, Lu N, Lian SS, Li H, et al
    The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.
    BMC Cancer. 2019;19:470.
    PubMed     Text format     Abstract available


  26. LIN CL, Wu SY, Huang WT, Feng YH, et al
    Subsequent thyroid disorders associated with treatment strategy in head and neck cancer patients: a nationwide cohort study.
    BMC Cancer. 2019;19:461.
    PubMed     Text format     Abstract available


  27. GAO Y, Yuan L, Pan B, Wang L, et al
    Resilience and associated factors among Chinese patients diagnosed with oral cancer.
    BMC Cancer. 2019;19:447.
    PubMed     Text format     Abstract available


  28. LIAO LJ, Hsu WL, Lo WC, Cheng PW, et al
    Health-related quality of life and utility in head and neck cancer survivors.
    BMC Cancer. 2019;19:425.
    PubMed     Text format     Abstract available


  29. NIU X, Fang Q, Liu F
    Role of intraparotid node metastasis in mucoepidermoid carcinoma of the parotid gland.
    BMC Cancer. 2019;19:417.
    PubMed     Text format     Abstract available


    April 2019
  30. LI C, Wang X, Wang X, Han C, et al
    A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
    BMC Cancer. 2019;19:397.
    PubMed     Text format     Abstract available


  31. SU W, Wang Y, Wang F, Sun S, et al
    Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway.
    BMC Cancer. 2019;19:400.
    PubMed     Text format     Abstract available


  32. LI JY, Huang WX, Zhou X, Chen J, et al
    Numb inhibits epithelial-mesenchymal transition via RBP-Jkappa-dependent Notch1/PTEN/FAK signaling pathway in tongue cancer.
    BMC Cancer. 2019;19:391.
    PubMed     Text format     Abstract available


  33. RODRIGUES-JUNIOR DM, Tan SS, de Souza Viana L, Carvalho AL, et al
    A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma.
    BMC Cancer. 2019;19:373.
    PubMed     Text format     Abstract available


  34. SUR S, Nakanishi H, Steele R, Ray RB, et al
    Depletion of PCAT-1 in head and neck cancer cells inhibits tumor growth and induces apoptosis by modulating c-Myc-AKT1-p38 MAPK signalling pathways.
    BMC Cancer. 2019;19:354.
    PubMed     Text format     Abstract available


  35. FU JY, Wu CX, Shen SK, Zheng Y, et al
    Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology.
    BMC Cancer. 2019;19:350.
    PubMed     Text format     Abstract available


  36. GAO G, Wang J, Kasperbauer JL, Tombers NM, et al
    Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
    BMC Cancer. 2019;19:352.
    PubMed     Text format     Abstract available


  37. BEUKHOF CM, Brabander T, van Nederveen FH, van Velthuysen MF, et al
    Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls.
    BMC Cancer. 2019;19:325.
    PubMed     Text format     Abstract available


  38. KOIZUMI W, Kitago M, Shinoda M, Yagi H, et al
    Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature.
    BMC Cancer. 2019;19:320.
    PubMed     Text format     Abstract available


  39. SONG B, Li R, Zuo Z, Tan J, et al
    LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
    BMC Cancer. 2019;19:297.
    PubMed     Text format     Abstract available


  40. SALAZAR-VEGA J, Ortiz-Prado E, Solis-Pazmino P, Gomez-Barreno L, et al
    Thyroid Cancer in Ecuador, a 16 years population-based analysis (2001-2016).
    BMC Cancer. 2019;19:294.
    PubMed     Text format     Abstract available


    March 2019
  41. CHEN YF, Liu CJ, Lin LH, Chou CH, et al
    Establishing of mouse oral carcinoma cell lines derived from transgenic mice and their use as syngeneic tumorigenesis models.
    BMC Cancer. 2019;19:281.
    PubMed     Text format     Abstract available


  42. CHE J, Wang Y, Zhang X, Chen J, et al
    Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis.
    BMC Cancer. 2019;19:282.
    PubMed     Text format     Abstract available


  43. HARLE A, Guillet J, Thomas J, Demange J, et al
    HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report.
    BMC Cancer. 2019;19:277.
    PubMed     Text format     Abstract available


  44. FORSLUND O, Sugiyama N, Wu C, Ravi N, et al
    A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin.
    BMC Cancer. 2019;19:265.
    PubMed     Text format     Abstract available


  45. RILEY A, Green V, Cheah R, McKenzie G, et al
    A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform.
    BMC Cancer. 2019;19:259.
    PubMed     Text format     Abstract available


  46. SHEN Z, Liao X, Shao Z, Feng M, et al
    Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability.
    BMC Cancer. 2019;19:262.
    PubMed     Text format     Abstract available


  47. WANG Y, Jiang Z, Xu C, Wang H, et al
    Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
    BMC Cancer. 2019;19:240.
    PubMed     Text format     Abstract available


  48. TESHIMA M, Tokita K, Ryo E, Matsumoto F, et al
    Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    BMC Cancer. 2019;19:245.
    PubMed     Text format     Abstract available


  49. MEINDL-BEINKER NM, Betge J, Gutting T, Burgermeister E, et al
    A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).
    BMC Cancer. 2019;19:231.
    PubMed     Text format     Abstract available


  50. HAYASHI Y, Iijima H, Isohashi F, Tsujii Y, et al
    The heart's exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study.
    BMC Cancer. 2019;19:195.
    PubMed     Text format     Abstract available


  51. MEHNERT JM, Varga A, Brose MS, Aggarwal RR, et al
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
    BMC Cancer. 2019;19:196.
    PubMed     Text format     Abstract available


  52. HUMMEL S, Kohlmann W, Kollmeyer TM, Jenkins R, et al
    The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
    BMC Cancer. 2019;19:190.
    PubMed     Text format     Abstract available


    February 2019
  53. A AL HAMAD M, Albisher HM, Al Saeed WR, Almumtin AT, et al
    BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
    BMC Cancer. 2019;19:170.
    PubMed     Text format     Abstract available


  54. SONG L, Wang Y, Weng G
    Metastasis in penile corpus cavernosum from esophageal squamous carcinoma after curative resection: a case report.
    BMC Cancer. 2019;19:162.
    PubMed     Text format     Abstract available


  55. ROT S, Kaune T, Taubert H, Greither T, et al
    Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
    BMC Cancer. 2019;19:155.
    PubMed     Text format     Abstract available


  56. GUANG Y, He W, Luo Y, Zhang H, et al
    Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up.
    BMC Cancer. 2019;19:147.
    PubMed     Text format     Abstract available


    January 2019
  57. CUI Z, Zhao Y
    microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    BMC Cancer. 2019;19:104.
    PubMed     Text format     Abstract available


  58. SUN XS, Liu LT, Liu SL, Guo SS, et al
    Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
    BMC Cancer. 2019;19:92.
    PubMed     Text format     Abstract available


  59. SIKORSKA J, Gawel D, Domek H, Rudzinska M, et al
    Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    BMC Cancer. 2019;19:85.
    PubMed     Text format     Abstract available


  60. YOU GR, Cheng AJ, Lee LY, Huang YC, et al
    Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    BMC Cancer. 2019;19:64.
    PubMed     Text format     Abstract available


  61. BAHIG H, Aubin F, Stagg J, Gologan O, et al
    Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma.
    BMC Cancer. 2019;19:68.
    PubMed     Text format     Abstract available


  62. YAO JJ, Zhu FT, Dong J, Liang ZB, et al
    Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area.
    BMC Cancer. 2019;19:37.
    PubMed     Text format     Abstract available


  63. PLUM PS, Gebauer F, Kramer M, Alakus H, et al
    HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    BMC Cancer. 2019;19:38.
    PubMed     Text format     Abstract available


  64. IWATSUBO T, Ishihara R, Morishima T, Maekawa A, et al
    Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
    BMC Cancer. 2019;19:3.
    PubMed     Text format     Abstract available


    December 2018
  65. LIANG YJ, Tang LQ, Sun XS, Fan YY, et al
    Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
    BMC Cancer. 2018;18:1297.
    PubMed     Text format     Abstract available


  66. LIU SL, Sun XS, Li XY, Chen QY, et al
    Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1279.
    PubMed     Text format     Abstract available


  67. ZHANG J, Peng H, Li WF, Zhang Y, et al
    Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1276.
    PubMed     Text format     Abstract available


  68. MAKITA Y, Kunii N, Sakurai D, Ihara F, et al
    Activated iNKT cells enhance the anti-tumor effect of antigen specific CD8 T cells on mesothelin-expressing salivary gland cancer.
    BMC Cancer. 2018;18:1254.
    PubMed     Text format     Abstract available


  69. HU YC, Tsai KW, Lee CC, Peng NJ, et al
    Which nasopharyngeal cancer patients need adaptive radiotherapy?
    BMC Cancer. 2018;18:1234.
    PubMed     Text format     Abstract available


  70. HATOYAMA K, Taniyama Y, Sakurai T, Sato C, et al
    Esophageal cancer with severe funnel chest treated by simultaneous funnel chest surgery and thoracoscopic esophagectomy: a case report.
    BMC Cancer. 2018;18:1212.
    PubMed     Text format     Abstract available


  71. SEGAOULA Z, Primot A, Lepretre F, Hedan B, et al
    Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.
    BMC Cancer. 2018;18:1219.
    PubMed     Text format     Abstract available


  72. ZARKESH M, Zadeh-Vakili A, Akbarzadeh M, Fanaei SA, et al
    The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
    BMC Cancer. 2018;18:1199.
    PubMed     Text format     Abstract available


    November 2018
  73. TALAGALA IA, Arambepola C
    Changes in quality of life following initial treatment of oesophageal carcinoma: a cohort study from Sri Lanka.
    BMC Cancer. 2018;18:1184.
    PubMed     Text format     Abstract available


  74. HUANG ZH, Ma XW, Zhang J, Li X, et al
    Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials.
    BMC Cancer. 2018;18:1170.
    PubMed     Text format     Abstract available


  75. KONG F, Zhou J, Du C, He X, et al
    Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1139.
    PubMed     Text format     Abstract available


  76. ZHANG J, Shi H, Jiang T, Liu Z, et al
    Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:1133.
    PubMed     Text format     Abstract available


  77. TALAGALA IA, Nawarathne M, Arambepola C
    Novel risk factors for primary prevention of oesophageal carcinoma: a case-control study from Sri Lanka.
    BMC Cancer. 2018;18:1135.
    PubMed     Text format     Abstract available


  78. GE X, Yu J, Wang Z, Xu Y, et al
    Comparative study of dual energy CT iodine imaging and standardized concentrations before and after chemoradiotherapy for esophageal cancer.
    BMC Cancer. 2018;18:1120.
    PubMed     Text format     Abstract available


  79. GRUPP K, Hofmann B, Kutup A, Bachmann K, et al
    Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
    BMC Cancer. 2018;18:1106.
    PubMed     Text format     Abstract available


  80. ZHANG L, Li Z, Liu Y, Xu S, et al
    Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.
    BMC Cancer. 2018;18:1107.
    PubMed     Text format     Abstract available


  81. CHUA KLM, Yeo ELL, Shihabudeen WA, Tan SH, et al
    Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC.
    BMC Cancer. 2018;18:1095.
    PubMed     Text format     Abstract available


    October 2018
  82. JACINTO AA, Batalha Filho ES, Viana LS, De Marchi P, et al
    Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.
    BMC Cancer. 2018;18:1026.
    PubMed     Text format     Abstract available


  83. LAVACCHI D, Nobili S, Brugia M, Paderi A, et al
    A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma.
    BMC Cancer. 2018;18:1024.
    PubMed     Text format     Abstract available


  84. BORGGREVE AS, Mook S, Verheij M, Mul VEM, et al
    Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
    BMC Cancer. 2018;18:1006.
    PubMed     Text format     Abstract available


  85. CHANG W, Tang L, Lu C, Wu M, et al
    Shear wave elastography in the evaluation of level VI lymph nodes in papillary thyroid carcinoma: combined with gray-scale ultrasound ex vivo.
    BMC Cancer. 2018;18:1001.
    PubMed     Text format     Abstract available


  86. ONERCI CELEBI O, Sener E, Hosal S, Cengiz M, et al
    Human papillomavirus infection in patients with laryngeal carcinoma.
    BMC Cancer. 2018;18:1005.
    PubMed     Text format     Abstract available


  87. XIAO J, Yang W, Xu B, Zhu H, et al
    Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    BMC Cancer. 2018;18:976.
    PubMed     Text format     Abstract available


  88. CHO JK, Kim MW, Choi IS, Moon UY, et al
    Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study.
    BMC Cancer. 2018;18:969.
    PubMed     Text format     Abstract available


  89. KIM SY, Kim SM, Chang HJ, Kim BW, et al
    SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer.
    BMC Cancer. 2018;18:956.
    PubMed     Text format     Abstract available


  90. LIU S, Guo L, Chen Q, Yu L, et al
    The improved cure fraction for esophageal cancer in Linzhou city.
    BMC Cancer. 2018;18:949.
    PubMed     Text format     Abstract available


    September 2018
  91. LIU H, Liu Z, Liu XW, Xu S, et al
    A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study.
    BMC Cancer. 2018;18:918.
    PubMed     Text format     Abstract available


  92. ZHONG L, Liu Y, Wang K, He Z, et al
    Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma.
    BMC Cancer. 2018;18:911.
    PubMed     Text format     Abstract available


  93. NG SP, Bahig H, Wang J, Cardenas CE, et al
    Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
    BMC Cancer. 2018;18:903.
    PubMed     Text format     Abstract available


  94. TOMASETTI M, Re M, Monaco F, Gaetani S, et al
    MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses.
    BMC Cancer. 2018;18:896.
    PubMed     Text format     Abstract available


  95. LIU F, Gong R, He B, Chen F, et al
    TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis.
    BMC Cancer. 2018;18:894.
    PubMed     Text format     Abstract available


  96. ISIDORI F, Malvi D, Fittipaldi S, Forcato C, et al
    Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report.
    BMC Cancer. 2018;18:889.
    PubMed     Text format     Abstract available


  97. ZHANG WY, Chen XX, Chen WH, Zhang H, et al
    Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy.
    BMC Cancer. 2018;18:879.
    PubMed     Text format     Abstract available


  98. JIN J, He XY
    Basal cell adenocarcinoma of the nasopharyngeal minor salivary glands: a case report and review of the literature.
    BMC Cancer. 2018;18:878.
    PubMed     Text format     Abstract available


  99. ZENDA S, Yamaguchi T, Yokota T, Miyaji T, et al
    Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
    BMC Cancer. 2018;18:873.
    PubMed     Text format     Abstract available


    August 2018
  100. ABBASZADEGAN MR, Taghehchian N, Li L, Aarabi A, et al
    Contribution of KCTD12 to esophageal squamous cell carcinoma.
    BMC Cancer. 2018;18:853.
    PubMed     Text format     Abstract available


  101. CHEN YH, Lu HI, Lo CM, Wang YM, et al
    The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    BMC Cancer. 2018;18:837.
    PubMed     Text format     Abstract available


  102. YOKOTA T, Serizawa M, Hosokawa A, Kusafuka K, et al
    PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
    BMC Cancer. 2018;18:826.
    PubMed     Text format     Abstract available


  103. WEHRHAN F, Buttner-Herold M, Distel L, Ries J, et al
    Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas.
    BMC Cancer. 2018;18:823.
    PubMed     Text format     Abstract available


  104. CHEN L, Zeng H, Yang J, Lu Y, et al
    Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:816.
    PubMed     Text format     Abstract available


  105. PUTTIPANYALEARS C, Arayataweegool A, Chalertpet K, Rattanachayoto P, et al
    TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:786.
    PubMed     Text format     Abstract available


  106. KORDOWSKI F, Kolarova J, Schafmayer C, Buch S, et al
    Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
    BMC Cancer. 2018;18:796.
    PubMed     Text format     Abstract available


  107. OFFMAN J, Muldrew B, O'Donovan M, Debiram-Beecham I, et al
    Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.
    BMC Cancer. 2018;18:784.
    PubMed     Text format     Abstract available


    July 2018
  108. MA J, Fu Y, Tu YY, Liu Y, et al
    Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
    BMC Cancer. 2018;18:758.
    PubMed     Text format     Abstract available


  109. YAO JJ, Jin YN, Wang SY, Zhang F, et al
    The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.
    BMC Cancer. 2018;18:740.
    PubMed     Text format     Abstract available


  110. VAN DER MERWE L, Wan Y, Cheong HJ, Perry C, et al
    A pilot study to profile salivary angiogenic factors to detect head and neck cancers.
    BMC Cancer. 2018;18:734.
    PubMed     Text format     Abstract available


  111. WANG J, Liu M, Shen J, Ouyang H, et al
    Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer.
    BMC Cancer. 2018;18:737.
    PubMed     Text format     Abstract available


  112. LOPES CB, Magalhaes LL, Teofilo CR, Alves APNN, et al
    Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer.
    BMC Cancer. 2018;18:721.
    PubMed     Text format     Abstract available


  113. PLATAIS C, Radhakrishnan R, Niklander Ebensperger S, Morgan R, et al
    Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
    BMC Cancer. 2018;18:723.
    PubMed     Text format     Abstract available


  114. HWANG-BO J, Bae MG, Park JH, Chung IS, et al
    3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    BMC Cancer. 2018;18:714.
    PubMed     Text format     Abstract available


  115. SOUSA NEVES F, Braga J, Cardoso da Costa J, Sequeira J, et al
    Kaposi's sarcoma of the conjunctiva and the eyelid leads to the diagnosis of human immunodeficiency virus infection - a case report.
    BMC Cancer. 2018;18:708.
    PubMed     Text format     Abstract available


    June 2018
  116. TORI M, Shimo T
    Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report.
    BMC Cancer. 2018;18:698.
    PubMed     Text format     Abstract available


  117. THEIN HH, Jembere N, Thavorn K, Chan KKW, et al
    Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.
    BMC Cancer. 2018;18:694.
    PubMed     Text format     Abstract available


  118. FU JY, Wu CX, Zhang CP, Gao J, et al
    Oral cancer incidence in Shanghai ---- a temporal trend analysis from 2003 to 2012.
    BMC Cancer. 2018;18:686.
    PubMed     Text format     Abstract available


  119. JANG JY, Choi N, Ko YH, Chung MK, et al
    Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1-2 N0 high-grade salivary gland cancer.
    BMC Cancer. 2018;18:672.
    PubMed     Text format     Abstract available


  120. GRONHOJ C, Jensen DH, Agander T, Kiss K, et al
    Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature.
    BMC Cancer. 2018;18:640.
    PubMed     Text format     Abstract available


  121. DEZIEL NC, Yi H, Stapleton HM, Huang H, et al
    A case-control study of exposure to organophosphate flame retardants and risk of thyroid cancer in women.
    BMC Cancer. 2018;18:637.
    PubMed     Text format     Abstract available


  122. LAI K, Matthews S, Wilmott JS, Killingsworth MC, et al
    Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    BMC Cancer. 2018;18:624.
    PubMed     Text format     Abstract available


    May 2018
  123. ZHANG Y, Chen Y, Liu Z, Lai R, et al
    ERK is a negative feedback regulator for IFN-gamma/STAT1 signaling by promoting STAT1 ubiquitination.
    BMC Cancer. 2018;18:613.
    PubMed     Text format     Abstract available


  124. YANG L, Liu L, Han B, Han W, et al
    Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report.
    BMC Cancer. 2018;18:618.
    PubMed     Text format     Abstract available


  125. YANG XL, Wang Y, Liang SB, He SS, et al
    Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    BMC Cancer. 2018;18:606.
    PubMed     Text format     Abstract available


  126. LUO R, Wu VWC, He B, Gao X, et al
    Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
    BMC Cancer. 2018;18:575.
    PubMed     Text format     Abstract available


  127. KAWAKAMI T, Tsushima T, Omae K, Ogawa H, et al
    Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
    BMC Cancer. 2018;18:573.
    PubMed     Text format     Abstract available


  128. NIE M, Liu C, Pan YC, Jiang CX, et al
    Development and evaluation of oral Cancer quality-of-life questionnaire (QOL-OC).
    BMC Cancer. 2018;18:523.
    PubMed     Text format     Abstract available


  129. PENHA RCC, Buexm LA, Rodrigues FR, de Castro TP, et al
    NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells.
    BMC Cancer. 2018;18:498.
    PubMed     Text format     Abstract available


  130. WANG H, Luo Q, Feng X, Zhang R, et al
    NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    BMC Cancer. 2018;18:500.
    PubMed     Text format     Abstract available


  131. CHEN Y, Tian T, Mao MJ, Deng WY, et al
    CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.
    BMC Cancer. 2018;18:514.
    PubMed     Text format     Abstract available


    April 2018
  132. EKIZOGLU S, Seven D, Ulutin T, Guliyev J, et al
    Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:477.
    PubMed     Text format     Abstract available


  133. ZICHI C, Tampellini M, Tucci M, Sonetto C, et al
    FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.
    BMC Cancer. 2018;18:470.
    PubMed     Text format     Abstract available


  134. ROGERS SN, Lowe D, Lowies C, Yeo ST, et al
    Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial.
    BMC Cancer. 2018;18:444.
    PubMed     Text format     Abstract available


  135. GAI C, Camussi F, Broccoletti R, Gambino A, et al
    Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
    BMC Cancer. 2018;18:439.
    PubMed     Text format     Abstract available


  136. HUANG XY, Gan RH, Xie J, She L, et al
    The oncogenic effects of HES1 on salivary adenoid cystic carcinoma cell growth and metastasis.
    BMC Cancer. 2018;18:436.
    PubMed     Text format     Abstract available


  137. FANG HJ, Shan SB, Zhou YH, Zhong LY, et al
    Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.
    BMC Cancer. 2018;18:422.
    PubMed     Text format     Abstract available


  138. FINAZZI T, Rordorf T, Ikenberg K, Huber GF, et al
    Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
    BMC Cancer. 2018;18:395.
    PubMed     Text format     Abstract available


  139. JIANYONG L, Zhihui L, Rixiang G, Jingqiang Z, et al
    Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.
    BMC Cancer. 2018;18:390.
    PubMed     Text format     Abstract available


  140. BARUL C, Carton M, Radoi L, Menvielle G, et al
    Occupational exposure to petroleum-based and oxygenated solvents and hypopharyngeal and laryngeal cancer in France: the ICARE study.
    BMC Cancer. 2018;18:388.
    PubMed     Text format     Abstract available


  141. LEUSINK FK, Koudounarakis E, Frank MH, Koole R, et al
    Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    BMC Cancer. 2018;18:385.
    PubMed     Text format     Abstract available


  142. YU Y, Wang H, Yan A, Wang H, et al
    Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
    BMC Cancer. 2018;18:383.
    PubMed     Text format     Abstract available


  143. VANNIMENUS C, Bricout H, Le Rouzic O, Mouawad F, et al
    Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study.
    BMC Cancer. 2018;18:372.
    PubMed     Text format     Abstract available


  144. LI XM, Song X, Zhao XK, Hu SJ, et al
    The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma.
    BMC Cancer. 2018;18:356.
    PubMed     Text format     Abstract available


    March 2018
  145. SETAKORNNUKUL J, Thephamongkhol K
    Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2018;18:329.
    PubMed     Text format     Abstract available


  146. PENG H, Tang LL, Liu X, Chen L, et al
    Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis.
    BMC Cancer. 2018;18:323.
    PubMed     Text format     Abstract available


  147. DE ABREU PM, Co ACG, Azevedo PL, do Valle IB, et al
    Frequency of HPV in oral cavity squamous cell carcinoma.
    BMC Cancer. 2018;18:324.
    PubMed     Text format     Abstract available


  148. KAUFFMANN RM, Hamner JB, Ituarte PHG, Yim JH, et al
    Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
    BMC Cancer. 2018;18:316.
    PubMed     Text format     Abstract available


  149. DU L, Wang Y, Sun X, Li H, et al
    Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.
    BMC Cancer. 2018;18:291.
    PubMed     Text format     Abstract available


  150. SCHLUTER A, Weller P, Kanaan O, Nel I, et al
    CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
    BMC Cancer. 2018;18:272.
    PubMed     Text format     Abstract available


  151. BROLIH S, Parks SK, Vial V, Durivault J, et al
    AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity.
    BMC Cancer. 2018;18:249.
    PubMed     Text format     Abstract available


  152. LU H, Yang S, Zhu H, Tong X, et al
    Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.
    BMC Cancer. 2018;18:251.
    PubMed     Text format     Abstract available


  153. SAKURAMOTO A, Hasegawa Y, Sugahara K, Komoda Y, et al
    New paste for severe stomatitis in patients undergoing head-and-neck cancer radiotherapy and/or chemotherapy with oral appliance.
    BMC Cancer. 2018;18:245.
    PubMed     Text format     Abstract available


  154. TAO Y, Gross N, Fan X, Yang J, et al
    Identification of novel enriched recurrent chimeric COL7A1-UCN2 in human laryngeal cancer samples using deep sequencing.
    BMC Cancer. 2018;18:248.
    PubMed     Text format     Abstract available


  155. NICKEL B, Brito JP, Moynihan R, Barratt A, et al
    Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study.
    BMC Cancer. 2018;18:242.
    PubMed     Text format     Abstract available


  156. DOVSAK T, Ihan A, Didanovic V, Kansky A, et al
    Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer.
    BMC Cancer. 2018;18:235.
    PubMed     Text format     Abstract available


  157. OKARU AO, Rullmann A, Farah A, Gonzalez de Mejia E, et al
    Comparative oesophageal cancer risk assessment of hot beverage consumption (coffee, mate and tea): the margin of exposure of PAH vs very hot temperatures.
    BMC Cancer. 2018;18:236.
    PubMed     Text format     Abstract available


    February 2018
  158. NARVAEZ C, Doemer C, Idel C, Setter C, et al
    Radiotherapy related skin toxicity (RAREST-01): Mepitel(R) film versus standard care in patients with locally advanced head-and-neck cancer.
    BMC Cancer. 2018;18:197.
    PubMed     Text format     Abstract available


  159. PEREIRA CM, de Carvalho AC, da Silva FR, Melendez ME, et al
    In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    BMC Cancer. 2018;18:193.
    PubMed     Text format     Abstract available


  160. HU X, Liao J, Zhao H, Chen F, et al
    NBS1 rs2735383 polymorphism is associated with an increased risk of laryngeal carcinoma.
    BMC Cancer. 2018;18:175.
    PubMed     Text format     Abstract available


  161. ROHATENSKY MG, Livingstone DM, Mintchev P, Barnes HK, et al
    Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification.
    BMC Cancer. 2018;18:166.
    PubMed     Text format     Abstract available


  162. JAYARAJAH U, Fernando A, Prabashani S, Fernando EA, et al
    Incidence and histological patterns of thyroid cancer in Sri Lanka 2001-2010: an analysis of national cancer registry data.
    BMC Cancer. 2018;18:163.
    PubMed     Text format     Abstract available


  163. HUANG GW, Xue YJ, Wu ZY, Xu XE, et al
    A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2018;18:147.
    PubMed     Text format     Abstract available


  164. HARADA K, Ferdous T, Ueyama Y
    PD-L1 expression in malignant salivary gland tumors.
    BMC Cancer. 2018;18:156.
    PubMed     Text format     Abstract available


  165. NOORDMAN BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, et al
    Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.
    BMC Cancer. 2018;18:142.
    PubMed     Text format     Abstract available


  166. MARIETTE C, Renaud F, Piessen G, Gele P, et al
    The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.
    BMC Cancer. 2018;18:139.
    PubMed     Text format     Abstract available


  167. PENSABENE M, Stanzione B, Cerillo I, Ciancia G, et al
    It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature.
    BMC Cancer. 2018;18:146.
    PubMed     Text format     Abstract available


  168. AL-KHYATT W, Tufarelli C, Khan R, Iftikhar SY, et al
    Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.
    BMC Cancer. 2018;18:121.
    PubMed     Text format     Abstract available


    January 2018
  169. GUO SS, Hu W, Chen QY, Li JM, et al
    Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT.
    BMC Cancer. 2018;18:114.
    PubMed     Text format     Abstract available


  170. CELESTINO R, Nome T, Pestana A, Hoff AM, et al
    CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension.
    BMC Cancer. 2018;18:68.
    PubMed     Text format     Abstract available


  171. BARROS FBA, Assao A, Garcia NG, Nonogaki S, et al
    Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.
    BMC Cancer. 2018;18:53.
    PubMed     Text format     Abstract available


  172. NAMANI A, Matiur Rahaman M, Chen M, Tang X, et al
    Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    BMC Cancer. 2018;18:46.
    PubMed     Text format     Abstract available


  173. GAO SG, Yang JQ, Ma ZK, Yuan X, et al
    Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2018;18:17.
    PubMed     Text format     Abstract available


  174. MAO MJ, Xue N, Wang XP, Chi PD, et al
    Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
    BMC Cancer. 2018;18:9.
    PubMed     Text format     Abstract available


  175. PATTERSON JM, Fay M, Exley C, McColl E, et al
    Feasibility and acceptability of combining cognitive behavioural therapy techniques with swallowing therapy in head and neck cancer dysphagia.
    BMC Cancer. 2018;18:1.
    PubMed     Text format     Abstract available


    December 2017
  176. KIM SY, Rho YS, Choi EC, Kim MS, et al
    Clinicopathological factors influencing the outcomes of surgical treatment in patients with T4a hypopharyngeal cancer.
    BMC Cancer. 2017;17:904.
    PubMed     Text format     Abstract available


  177. CHEN J, Li S, Xiao Y, Zou X, et al
    p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:846.
    PubMed     Text format     Abstract available


  178. PRITCHETT NR, Burgert SL, Murphy GA, Brockman JD, et al
    Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya.
    BMC Cancer. 2017;17:835.
    PubMed     Text format     Abstract available


  179. QUINTANILHA JCF, Visacri MB, Amaral LS, Lima CSP, et al
    Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report.
    BMC Cancer. 2017;17:831.
    PubMed     Text format     Abstract available


  180. KANO K, Aoyama T, Nakajima T, Maezawa Y, et al
    Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospect
    BMC Cancer. 2017;17:812.
    PubMed     Text format     Abstract available


    November 2017
  181. SHAIKH MH, Khan AI, Sadat A, Chowdhury AH, et al
    Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
    BMC Cancer. 2017;17:792.
    PubMed     Text format     Abstract available


  182. ZHANG LL, Zhou GQ, Qi ZY, He XJ, et al
    Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy.
    BMC Cancer. 2017;17:788.
    PubMed     Text format     Abstract available


  183. HIGUCHI Y, Motoki T, Ishida H, Kanamitsu K, et al
    Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report.
    BMC Cancer. 2017;17:775.
    PubMed     Text format     Abstract available


  184. MURAKAMI M, Otsuka K, Goto S, Ariyoshi T, et al
    Thoracoscopic and hand assisted laparoscopic esophagectomy with radical lymph node dissection for esophageal squamous cell carcinoma in the left lateral decubitus position: a single center retrospective analysis of 654 patients.
    BMC Cancer. 2017;17:748.
    PubMed     Text format     Abstract available


  185. JIN Y, Liu M, Cheng L, Chen L, et al
    Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report.
    BMC Cancer. 2017;17:735.
    PubMed     Text format     Abstract available


  186. DI L, Fu KI, Xie R, Wu X, et al
    A modified endoscopic submucosal dissection for a superficial hypopharyngeal cancer: a case report and technical discussion.
    BMC Cancer. 2017;17:712.
    PubMed     Text format     Abstract available


    October 2017
  187. ROCHA TAH, Thomaz EBAF, da Silva NC, de Sousa Queiroz RC, et al
    Oral primary care: an analysis of its impact on the incidence and mortality rates of oral cancer.
    BMC Cancer. 2017;17:706.
    PubMed     Text format     Abstract available


  188. NIE X, Tan Z, Ge M
    Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    BMC Cancer. 2017;17:702.
    PubMed     Text format     Abstract available


  189. YAN DF, Zhang WB, Ke SB, Zhao F, et al
    The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:678.
    PubMed     Text format     Abstract available


    September 2017
  190. MA X, Xia QJ, Li G, Wang TX, et al
    Aesthetic principles access thyroidectomy produces the best cosmetic outcomes as assessed using the patient and observer scar assessment scale.
    BMC Cancer. 2017;17:654.
    PubMed     Text format     Abstract available


  191. REYNOLDS KL, Bedard PL, Lee SH, Lin CC, et al
    A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
    BMC Cancer. 2017;17:646.
    PubMed     Text format     Abstract available


  192. YANG L, Xia L, Wang Y, He S, et al
    Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:628.
    PubMed     Text format     Abstract available


  193. DYCKHOFF G, Plinkert PK, Ramroth H
    A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    BMC Cancer. 2017;17:609.
    PubMed     Text format     Abstract available


    August 2017
  194. DU L, Zhang XX, Feng LC, Qu BL, et al
    Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
    BMC Cancer. 2017;17:582.
    PubMed     Text format     Abstract available


  195. CHRISTENSEN A, Kiss K, Lelkaitis G, Juhl K, et al
    Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
    BMC Cancer. 2017;17:572.
    PubMed     Text format     Abstract available


  196. LI Y, Chen QY, Tang LQ, Liu LT, et al
    Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
    BMC Cancer. 2017;17:567.
    PubMed     Text format     Abstract available


  197. VAN VULPEN JK, Siersema PD, van Hillegersberg R, Nieuwenhuijzen GAP, et al
    Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: design of a randomized controlled trial.
    BMC Cancer. 2017;17:552.
    PubMed     Text format     Abstract available


  198. HUANG H, Wang XP, Li XH, Chen H, et al
    Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2017;17:544.
    PubMed     Text format     Abstract available


    July 2017
  199. HAAG GM, Stocker G, Quidde J, Jaeger D, et al
    Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
    BMC Cancer. 2017;17:509.
    PubMed     Text format     Abstract available


  200. LIANG SB, Teng JJ, Hu XF, Yang XL, et al
    Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    BMC Cancer. 2017;17:506.
    PubMed     Text format     Abstract available


  201. LAI J, Xu P, Jiang X, Zhou S, et al
    Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report.
    BMC Cancer. 2017;17:507.
    PubMed     Text format     Abstract available


  202. ZHAO W, Mo Y, Wang S, Midorikawa K, et al
    Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    BMC Cancer. 2017;17:489.
    PubMed     Text format     Abstract available


  203. GUAN H, Guo Z, Liang W, Li H, et al
    Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
    BMC Cancer. 2017;17:486.
    PubMed     Text format     Abstract available


  204. SERVAGI-VERNAT S, Crehange G, Bonnetain F, Mertens C, et al
    Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE).
    BMC Cancer. 2017;17:483.
    PubMed     Text format     Abstract available


  205. FU X, Shen C, Wang H, Chen F, et al
    Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    BMC Cancer. 2017;17:479.
    PubMed     Text format     Abstract available


  206. SU Y, Yu QH, Wang XY, Yu LP, et al
    JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    BMC Cancer. 2017;17:477.
    PubMed     Text format     Abstract available


  207. RUMLEY CN, Lee MT, Holloway L, Rai R, et al
    Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.
    BMC Cancer. 2017;17:475.
    PubMed     Text format     Abstract available


    June 2017
  208. YU X, Li W, Xia Z, Xie L, et al
    Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    BMC Cancer. 2017;17:449.
    PubMed     Text format     Abstract available


  209. TANG H, Tan L, Shen Y, Wang H, et al
    CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous
    BMC Cancer. 2017;17:450.
    PubMed     Text format     Abstract available


  210. IMANISHI Y, Ozawa H, Sakamoto K, Fujii R, et al
    Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer.
    BMC Cancer. 2017;17:445.
    PubMed     Text format     Abstract available


  211. ERKIZAN HV, Johnson K, Ghimbovschi S, Karkera D, et al
    African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks.
    BMC Cancer. 2017;17:426.
    PubMed     Text format     Abstract available


  212. VAN GINKEL JH, Huibers MMH, van Es RJJ, de Bree R, et al
    Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    BMC Cancer. 2017;17:428.
    PubMed     Text format     Abstract available


  213. LONKVIST CK, Lonbro S, Vinther A, Zerahn B, et al
    Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial.
    BMC Cancer. 2017;17:400.
    PubMed     Text format     Abstract available


  214. REYNOLDS JV, Preston SR, O'Neill B, Baeksgaard L, et al
    ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS).
    BMC Cancer. 2017;17:401.
    PubMed     Text format     Abstract available


    May 2017
  215. KREYCY N, Gotzian C, Fleming T, Flechtenmacher C, et al
    Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2017;17:382.
    PubMed     Text format     Abstract available


  216. HASEGAWA H, Kusumi Y, Asakawa T, Maeda M, et al
    Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium.
    BMC Cancer. 2017;17:381.
    PubMed     Text format     Abstract available


  217. FANG J, Li X, Ma D, Liu X, et al
    Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    BMC Cancer. 2017;17:375.
    PubMed     Text format     Abstract available


  218. OLUIC B, Paunovic I, Loncar Z, Djukic V, et al
    Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience.
    BMC Cancer. 2017;17:371.
    PubMed     Text format     Abstract available


  219. MAGNUSSEN SN, Hadler-Olsen E, Costea DE, Berg E, et al
    Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - beta1 (TGF-beta1) and potential effects on migration and invasion.
    BMC Cancer. 2017;17:350.
    PubMed     Text format     Abstract available


  220. KULASINGHE A, Perry C, Kenny L, Warkiani ME, et al
    PD-L1 expressing circulating tumour cells in head and neck cancers.
    BMC Cancer. 2017;17:333.
    PubMed     Text format     Abstract available


  221. LONJOU C, Damiola F, Moissonnier M, Durand G, et al
    Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
    BMC Cancer. 2017;17:328.
    PubMed     Text format     Abstract available


  222. DEMOOR-GOLDSCHMIDT C, Drui D, Doutriaux I, Michel G, et al
    A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.
    BMC Cancer. 2017;17:326.
    PubMed     Text format     Abstract available


  223. YOKOTA T, Ogawa T, Takahashi S, Okami K, et al
    Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    BMC Cancer. 2017;17:314.
    PubMed     Text format     Abstract available


    April 2017
  224. ZHAO H, Wang Y, Wang MJ, Zhang ZH, et al
    Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma.
    BMC Cancer. 2017;17:296.
    PubMed     Text format     Abstract available


  225. LIN CL, Lee WT, Ou CY, Hsiao JR, et al
    Regular recreational physical activity and risk of head and neck cancer.
    BMC Cancer. 2017;17:286.
    PubMed     Text format     Abstract available


  226. WAGNER M, Khoury H, Bennetts L, Berto P, et al
    Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.
    BMC Cancer. 2017;17:272.
    PubMed     Text format     Abstract available


  227. GREUTER MJ, Schouten CS, Castelijns JA, de Graaf P, et al
    Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F-FDG-PET-CT and/or diffusion-weighted MRI.
    BMC Cancer. 2017;17:256.
    PubMed     Text format     Abstract available


  228. XIONG L, Zeng XL, Guo CK, Liu AW, et al
    Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
    BMC Cancer. 2017;17:254.
    PubMed     Text format     Abstract available


    March 2017
  229. VARADARAJAN VV, Pace EK, Patel V, Sawhney R, et al
    Follicular thyroid carcinoma metastasis to the facial skeleton: a systematic review.
    BMC Cancer. 2017;17:225.
    PubMed     Text format     Abstract available


  230. VAN DEN BOSCH S, Dijkema T, Kunze-Busch MC, Terhaard CH, et al
    Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
    BMC Cancer. 2017;17:208.
    PubMed     Text format     Abstract available


    February 2017
  231. KOMAKI K, Kusaba T, Tanaka M, Kado H, et al
    Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
    BMC Cancer. 2017;17:144.
    PubMed     Text format     Abstract available


  232. BRADLEY NL, Wiseman SM
    Papillary thyroid microcarcinoma: the significance of high risk features.
    BMC Cancer. 2017;17:142.
    PubMed     Text format     Abstract available


  233. CHO YJ, Kim DY, Park EC, Han KT, et al
    Thyroid fine-needle aspiration biopsy positively correlates with increased diagnosis of thyroid cancer in South Korean patients.
    BMC Cancer. 2017;17:114.
    PubMed     Text format     Abstract available


    January 2017
  234. MORITA FH, Bernardo WM, Ide E, Rocha RS, et al
    Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
    BMC Cancer. 2017;17:54.
    PubMed     Text format     Abstract available


  235. LIN MC, Lin YC, Chen ST, Young TH, et al
    Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.
    BMC Cancer. 2017;17:18.
    PubMed     Text format     Abstract available


  236. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    PubMed     Text format     Abstract available


    January 2016
  237. BRENNAN K, Holsinger C, Dosiou C, Sunwoo JB, et al
    Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
    BMC Cancer. 2016;16:736.
    PubMed     Text format     Abstract available


  238. HARADA K, Ferdous T, Cui D, Kuramitsu Y, et al
    Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.
    BMC Cancer. 2016;16:548.
    PubMed     Text format     Abstract available


  239. CARLBERG M, Hedendahl L, Ahonen M, Koppel T, et al
    Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data.
    BMC Cancer. 2016;16:426.
    PubMed     Text format     Abstract available


  240. MARITAZ C, Metz C, Baba-Hamed N, Jardin-Szucs M, et al
    Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event.
    BMC Cancer. 2016;16:384.
    PubMed     Text format     Abstract available


  241. VOJTECHOVA Z, Sabol I, Salakova M, Smahelova J, et al
    Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    BMC Cancer. 2016;16:382.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: